Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DRD Stock Summary
Top 10 Correlated ETFs
DRD
In the News
DRD Financial details
Company Rating
Strong Buy
Market Cap
727.97M
Income
144.09M
Revenue
638.2M
Book val./share
4
Cash/share
0.97
Dividend
0.46
Dividend %
6.12%
Employees
927
Optionable
No
Shortable
Yes
Earnings
21 Aug 2024
P/E
9.33
Forward P/E
-
PEG
-1.07
P/S
2.26
P/B
1.91
P/C
8.74
P/FCF
24.32
Quick Ratio
3.6
Current Ratio
4.47
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
1.68
EPS next Y
-
EPS next Q
-
EPS this Y
13.64%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
67.53%
Revenue last 5Y
14.75%
Revenue Q/Q
2.05%
EPS Q/Q
-22.92%
-
-
-
-
SMA20
12.5%
SMA50
12.5%
SMA100
-
Inst Own
13.53%
Inst Trans
0.87%
ROA
16%
ROE
22%
ROC
0.19%
Gross Margin
29%
Oper. Margin
26%
Profit Margin
23%
Payout
40%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6.48-13.85
52W High
-34.77%
52W Low
+41.33%
RSI
56
Rel Volume
0.4
Avg Volume
340.32K
Volume
136.78K
Perf Week
-2.42%
Perf Month
6.27%
Perf Quarter
-2.19%
Perf Half Y
-8.23%
-
-
-
-
Beta
1.353
-
-
Volatility
0.12%, 0.35%
Prev Close
-0.35%
Price
8.48
Change
1.07%
DRD Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 41.56 | 54.35 | 61.62 | 59.74 | 63.94 | |
Net income per share | 1.18 | 8.25 | 16.84 | 13.12 | 14.91 | |
Operating cash flow per share | 4.34 | 14.66 | 18.4 | 17.48 | 19.26 | |
Free cash flow per share | -0.89 | 12.31 | 13.77 | 10.66 | 5.94 | |
Cash per share | 4.21 | 22.28 | 25.49 | 29.35 | 28.62 | |
Book value per share | 40.46 | 52.47 | 56.37 | 63.49 | 72.99 | |
Tangible book value per share | 40.46 | 52.47 | 56.37 | 63.49 | 72.99 | |
Share holders equity per share | 40.46 | 52.47 | 56.37 | 63.49 | 72.99 | |
Interest debt per share | 1.35 | 1.51 | 1.33 | 1.46 | 1.28 | |
Market cap | 2.72B | 20.71B | 13.4B | 8.21B | 17.12B | |
Enterprise value | 2.45B | 19.04B | 11.27B | 5.75B | 14.7B | |
P/E ratio | 34.69 | 32.61 | 9.31 | 7.31 | 13.36 | |
Price to sales ratio | 0.99 | 4.95 | 2.54 | 1.6 | 3.11 | |
POCF ratio | 9.44 | 18.35 | 8.52 | 5.48 | 10.34 | |
PFCF ratio | -46.07 | 21.85 | 11.38 | 8.99 | 33.53 | |
P/B Ratio | 1.01 | 5.13 | 2.78 | 1.51 | 2.73 | |
PTB ratio | 1.01 | 5.13 | 2.78 | 1.51 | 2.73 | |
EV to sales | 0.89 | 4.55 | 2.14 | 1.12 | 2.67 | |
Enterprise value over EBITDA | 6.96 | 14.44 | 4.94 | 3.53 | 7.83 | |
EV to operating cash flow | 8.51 | 16.87 | 7.17 | 3.84 | 8.88 | |
EV to free cash flow | -41.53 | 20.09 | 9.57 | 6.29 | 28.79 | |
Earnings yield | 0.03 | 0.03 | 0.11 | 0.14 | 0.07 | |
Free cash flow yield | -0.02 | 0.05 | 0.09 | 0.11 | 0.03 | |
Debt to equity | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to assets | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | -0.76 | -1.27 | -0.93 | -1.51 | -1.29 | |
Current ratio | 1.43 | 2.94 | 5.03 | 4.92 | 4.47 | |
Interest coverage | 2.34 | 13.63 | 30.85 | 17.93 | 20.21 | |
Income quality | 2.74 | 1.15 | 1.09 | 1.33 | 1.29 | |
Dividend Yield | 0 | 0.03 | 0.05 | 0.06 | 0.03 | |
Payout ratio | 0 | 0.89 | 0.45 | 0.46 | 0.4 | |
Sales general and administrative to revenue | 0.03 | 0.07 | 0.01 | 0.03 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.68 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.2 | -0.16 | -0.25 | -0.39 | -0.69 | |
Capex to revenue | -0.13 | -0.04 | -0.08 | -0.11 | -0.21 | |
Capex to depreciation | -2.05 | -0.67 | -1.57 | -2.18 | -5.27 | |
Stock based compensation to revenue | 0.01 | 0.05 | -0.01 | 0 | 0 | |
Graham number | 32.79 | 98.68 | 146.14 | 136.89 | 156.47 | |
ROIC | 0.05 | 0.15 | 0.27 | 0.18 | 0.17 | |
Return on tangible assets | 0.06 | 0.11 | 0.23 | 0.16 | 0.16 | |
Graham Net | -13.33 | 4.61 | 10.8 | 13.75 | 10.28 | |
Working capital | 197.9M | 1.44B | 2.14B | 2.45B | 2.5B | |
Tangible asset value | -90.2M | 4.04B | 4.82B | 5.44B | 6.27B | |
Net current asset value | -715.3M | 554.8M | 1.15B | 1.44B | 1.33B | |
Invested capital | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Average receivables | 81.6M | 111.65M | 143.3M | 139.1M | 136.5M | |
Average payables | 361.2M | 449M | 415.85M | 391M | 477.1M | |
Average inventory | 268.8M | 314M | 331.7M | 364.65M | 401.45M | |
Days sales outstanding | 9.51 | 13.2 | 9.37 | 10.19 | 8.64 | |
Days payables outstanding | 59.91 | 59.49 | 38.02 | 41.86 | 49.01 | |
Days of inventory on hand | 43.53 | 40.18 | 36.63 | 37.98 | 38.6 | |
Receivables turnover | 38.36 | 27.66 | 38.94 | 35.82 | 42.25 | |
Payables turnover | 6.09 | 6.14 | 9.6 | 8.72 | 7.45 | |
Inventory turnover | 8.38 | 9.08 | 9.97 | 9.61 | 9.46 | |
ROE | 0.03 | 0.16 | 0.3 | 0.21 | 0.2 | |
Capex per share | -5.23 | -2.35 | -4.63 | -6.82 | -13.32 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
Metric | History | 2020-06-30 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 62.97 | 1.98 | 1.79 | 1.81 | 1.85 | |
Net income per share | 9.56 | 0.47 | 0.36 | 0.48 | 0.37 | |
Operating cash flow per share | 16.99 | 0.66 | 0.43 | 0.63 | 0.46 | |
Free cash flow per share | 19.71 | 0.36 | 0.17 | 0.16 | -0.21 | |
Cash per share | 25.81 | 1.8 | 1.64 | 1.52 | 0.97 | |
Book value per share | 60.8 | 3.87 | 3.86 | 3.86 | 4 | |
Tangible book value per share | 60.8 | 3.87 | 3.86 | 3.86 | 4 | |
Share holders equity per share | 60.8 | 3.87 | 3.86 | 3.86 | 4 | |
Interest debt per share | 0.71 | 0.03 | 0.02 | 0.02 | 0.01 | |
Market cap | 17.88B | 503.63M | 635.22M | 914.05M | 684.48M | |
Enterprise value | 16.21B | 352.66M | 497.11M | 785.33M | 602.73M | |
P/E ratio | 7.04 | 3.09 | 5.14 | 5.58 | 5.43 | |
Price to sales ratio | 4.27 | 2.96 | 4.15 | 5.86 | 4.3 | |
POCF ratio | 15.83 | 8.85 | 17.28 | 16.91 | 17.38 | |
PFCF ratio | 13.65 | 16.17 | 44.08 | 67.27 | -37.84 | |
P/B Ratio | 4.42 | 1.52 | 1.92 | 2.75 | 1.99 | |
PTB ratio | 4.42 | 1.52 | 1.92 | 2.75 | 1.99 | |
EV to sales | 3.87 | 2.07 | 3.24 | 5.04 | 3.79 | |
Enterprise value over EBITDA | 22.17 | 7.09 | 12.36 | 15.34 | 14.08 | |
EV to operating cash flow | 14.36 | 6.2 | 13.52 | 14.53 | 15.3 | |
EV to free cash flow | 12.37 | 11.32 | 34.5 | 57.8 | -33.32 | |
Earnings yield | 0.04 | 0.08 | 0.05 | 0.04 | 0.05 | |
Free cash flow yield | 0.07 | 0.06 | 0.02 | 0.01 | -0.03 | |
Debt to equity | 0.01 | 0 | 0 | 0 | 0 | |
Debt to assets | 0.01 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -2.28 | -3.04 | -3.43 | -2.51 | -1.91 | |
Current ratio | 2.94 | 4.92 | 5.35 | 4.47 | 3.67 | |
Interest coverage | 0 | 26.48 | 80.2 | 45.99 | 72.48 | |
Income quality | 1.78 | 1.4 | 1.19 | 1.32 | 1.25 | |
Dividend Yield | 0 | 0.02 | 0.03 | 0.01 | 0.04 | |
Payout ratio | 0 | 0.25 | 0.64 | 0.21 | 0.95 | |
Sales general and administrative to revenue | 0.07 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.16 | -0.45 | -0.61 | -0.75 | -1.46 | |
Capex to revenue | 0.04 | -0.15 | -0.15 | -0.26 | -0.36 | |
Capex to depreciation | 0 | -2.65 | -2.86 | -5.75 | -6.34 | |
Stock based compensation to revenue | 0 | -0.05 | 0 | -0.01 | -0.17 | |
Graham number | 114.33 | 6.43 | 5.59 | 6.43 | 5.74 | |
ROIC | 0.2 | 0.1 | 0.07 | 0.1 | 0.07 | |
Return on tangible assets | 0.11 | 0.09 | 0.07 | 0.09 | 0.07 | |
Graham Net | 5.35 | 0.85 | 0.73 | 0.55 | 0.22 | |
Working capital | 1.44B | 149.64M | 140.83M | 132.1M | 110.53M | |
Tangible asset value | 4.04B | 332.06M | 330.92M | 332.12M | 344.54M | |
Net current asset value | 554.8M | 87.82M | 76.69M | 70.6M | 42.86M | |
Invested capital | 0.01 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 3.25 | 4.62 | 6.27 | 3.98 | 23.35 | |
Days payables outstanding | 14.67 | 26.24 | 23.85 | 31.28 | 24.66 | |
Days of inventory on hand | 9.91 | 17.07 | 16.99 | 18.47 | 20.29 | |
Receivables turnover | 27.66 | 19.49 | 14.36 | 22.64 | 3.85 | |
Payables turnover | 6.14 | 3.43 | 3.77 | 2.88 | 3.65 | |
Inventory turnover | 9.08 | 5.27 | 5.3 | 4.87 | 4.43 | |
ROE | 0.16 | 0.12 | 0.09 | 0.12 | 0.09 | |
Capex per share | 2.73 | -0.3 | -0.26 | -0.47 | -0.67 |
DRD Frequently Asked Questions
What is DRDGOLD Limited stock symbol ?
DRDGOLD Limited is a ZA stock and trading under the symbol DRD
What is DRDGOLD Limited stock quote today ?
DRDGOLD Limited stock price is $8.48 today.
Is DRDGOLD Limited stock public?
Yes, DRDGOLD Limited is a publicly traded company.